In the latest session, Annovis Bio Inc (NYSE: ANVS) closed at $11.90 down -1.08% from its previous closing price of $12.03. In other words, the price has decreased by -$0.13 from its previous closing price. On the day, 249460 shares were traded.
Ratios:
For a deeper understanding of Annovis Bio Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.87 and its Current Ratio is at 2.87. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Canaccord Genuity on December 29, 2023, initiated with a Buy rating and assigned the stock a target price of $36.
On July 07, 2021, Maxim Group reiterated its Buy rating and also lowered its target price recommendation from $45 to $150.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANVS now has a Market Capitalization of 131.03M and an Enterprise Value of 124.68M.
Stock Price History:
Over the past 52 weeks, ANVS has reached a high of $23.89, while it has fallen to a 52-week low of $5.42. The 50-Day Moving Average of the stock is 10.21, while the 200-Day Moving Average is calculated to be 10.97.
Shares Statistics:
For the past three months, ANVS has traded an average of 292.59K shares per day and 406.55k over the past ten days. A total of 8.16M shares are outstanding, with a floating share count of 7.80M. Insiders hold about 27.11% of the company’s shares, while institutions hold 11.78% stake in the company. Shares short for ANVS as of Mar 15, 2024 were 1.35M with a Short Ratio of 4.61, compared to 1.37M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 12.74% and a Short% of Float of 17.03%.
Earnings Estimates
There are 4 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$1.3 for the current quarter, with a high estimate of -$1.06 and a low estimate of -$1.63, while EPS last year was -$0.38. The consensus estimate for the next quarter is -$0.86, with high estimates of -$0.34 and low estimates of -$1.21.
Analysts are recommending an EPS of between -$4.93 and -$5.34 for the fiscal current year, implying an average EPS of -$5.04. EPS for the following year is -$3.1, with 4 analysts recommending between -$1.92 and -$4.48.
